ArrowMark Colorado Holdings’s Biogen BIIB Stock Holding History

ArrowMark Colorado Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,475	Closed	-$596K	–	280
2015 Q2	$596K	Buy	+1,475	New	+$592K	0.01%	261
2014 Q3	–	Sell	-7,058	Closed	-$2.23M	–	298
2014 Q2	$2.23M	Hold	7,058	–	–	0.06%	182
2014 Q1	$2.16M	Buy	7,058 +58	+0.8%	+$18.4K	0.07%	176
2013 Q4	$1.96M	Buy	+7,000	New	+$1.81M	0.06%	179
2013 Q3	–	Sell	-1,450	Closed	-$312K	–	304
2013 Q2	$312K	Buy	+1,450	New	+$310K	0.08%	101

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

ArrowMark Colorado Holdings's BIIB Position: Q3 2015 in Review

ArrowMark Colorado Holdings sold out of Biogen (BIIB) in Q3 2015, closing a stake of 1,475 shares — an estimated $596K sold.

ArrowMark Colorado Holdings first reported a position in BIIB in Q2 2013 and held it in 5 quarters. The position peaked at $2.23M in Q2 2014. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

ArrowMark Colorado Holdings reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
ArrowMark Colorado Holdings sold 1,475 Biogen shares in Q3 2015, an estimated $596K.
ArrowMark Colorado Holdings first reported a position in Biogen in Q2 2013 and held it in 5 quarters.
ArrowMark Colorado Holdings's Biogen position peaked at $2.23M in Q2 2014.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2015, filed 16 Nov 2015.